FDA Adverse Event Injury Summary report: N

REGENEREX TIBIAL COMPONENTS

MDR report key: 6676522 · Received June 29, 2017

Report

Report Number
0001825034-2017-04448
Event Type
Injury
Date Received
June 29, 2017
Date of Event
August 24, 2015
Report Date
September 30, 2017
Manufacturer
BIOMET ORTHOPEDICS
Product Code
MBH
PMA / PMN Number
PK080361
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
UT, US
Reporter Occupation
MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE

Narratives

Additional Manufacturer Narrative · 1

(B)(4). CONCOMITANT MEDICAL PRODUCTS - REGENEREX 34 MM PATELLA CATALOG 141357 LOT 344230; VANGUARD TIBIAL BEARING 63/67 X 12 CATALOG EP-183522 LOT 911000; VANGUARD FEMUR RIGHT 60 MM CATALOG 183044 LOT 386610; REGENEREX TIBIAL TRAY 67 MM CATALOG 141272 LOT 299140. CUSTOMER HAS NOT INDICATED THAT THE PRODUCT WILL BE RETURNED TO ZIMMER BIOMET FOR INVESTIGATION. THE INVESTIGATION IS IN PROCESS. ONCE THE INVESTIGATION HAS BEEN COMPLETED, A FOLLOW-UP MDR WILL BE SUBMITTED. MULTIPLE MDR REPORTS WERE FILED FOR THIS EVENT, PLEASE SEE ASSOCIATED REPORTS: 1822565-2017-03198, 1825034-2017-04449, 1825034-2017-04446, AND 1825034-2017-04447.

Additional Manufacturer Narrative · 1

THIS FOLLOW-UP REPORT IS BEING SUBMITTED TO RELAY ADDITIONAL INFORMATION. REPORTED EVENT WAS UNABLE TO BE CONFIRMED DUE TO LIMITED INFORMATION RECEIVED FROM THE CUSTOMER. DHR WAS REVIEWED AND NO DISCREPANCIES RELEVANT TO THE REPORTED EVENT WERE FOUND. ROOT CAUSE WAS UNABLE TO BE DETERMINED AS THE NECESSARY INFORMATION TO ADEQUATELY INVESTIGATE THE REPORTED EVENT WAS NOT PROVIDED.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE PATIENT UNDERWENT A RIGHT TOTAL KNEE REVISION APPROXIMATELY ONE YEAR POST IMPLANTATION DUE TO UNKNOWN REASONS. ATTEMPTS HAVE BEEN MADE AND ADDITIONAL INFORMATION ON THE REPORTED EVENT IS UNAVAILABLE AT THIS TIME.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
457175 REGENEREX TIBIAL COMPONENTS PROSTHESIS, KNEE MBH BIOMET ORTHOPEDICS 454860

Patients

Seq Age Sex Outcome Treatment
1 48 YR Hospitalization| R